Cargando…

Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”

Detalles Bibliográficos
Autores principales: Zhao, Ling-Yue, Luo, Yi-Jun, Zhu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345323/
https://www.ncbi.nlm.nih.gov/pubmed/30718943
http://dx.doi.org/10.2147/DDDT.S185297
_version_ 1783389552190160896
author Zhao, Ling-Yue
Luo, Yi-Jun
Zhu, Jing
author_facet Zhao, Ling-Yue
Luo, Yi-Jun
Zhu, Jing
author_sort Zhao, Ling-Yue
collection PubMed
description
format Online
Article
Text
id pubmed-6345323
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63453232019-02-04 Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients” Zhao, Ling-Yue Luo, Yi-Jun Zhu, Jing Drug Des Devel Ther Letter Dove Medical Press 2019-01-21 /pmc/articles/PMC6345323/ /pubmed/30718943 http://dx.doi.org/10.2147/DDDT.S185297 Text en © 2019 Zhao et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Letter
Zhao, Ling-Yue
Luo, Yi-Jun
Zhu, Jing
Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
title Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
title_full Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
title_fullStr Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
title_full_unstemmed Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
title_short Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
title_sort letter regarding the article, “a randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin ii receptor blockers in hypertensive type 2 diabetic patients”
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345323/
https://www.ncbi.nlm.nih.gov/pubmed/30718943
http://dx.doi.org/10.2147/DDDT.S185297
work_keys_str_mv AT zhaolingyue letterregardingthearticlearandomizeddoubleblindclinicaltrialofcanrenonevshydrochlorothiazideinadditiontoangiotensiniireceptorblockersinhypertensivetype2diabeticpatients
AT luoyijun letterregardingthearticlearandomizeddoubleblindclinicaltrialofcanrenonevshydrochlorothiazideinadditiontoangiotensiniireceptorblockersinhypertensivetype2diabeticpatients
AT zhujing letterregardingthearticlearandomizeddoubleblindclinicaltrialofcanrenonevshydrochlorothiazideinadditiontoangiotensiniireceptorblockersinhypertensivetype2diabeticpatients